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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYDirect reprogramming of adult somatic cells into alternative cell types has been shown for several lineages. We previously showed that
GATA4, MEF2C, and TBX5 (GMT) directly reprogrammed nonmyocyte mouse heart cells into induced cardiomyocyte-like cells (iCMs)
in vitro and in vivo. However, GMTalone appears insufficient in human fibroblasts, at least in vitro. Here, we show that GMTplus ESRRG
andMESP1 induced global cardiac gene-expression and phenotypic shifts in human fibroblasts derived from embryonic stem cells, fetal
heart, and neonatal skin. Adding Myocardin and ZFPM2 enhanced reprogramming, including sarcomere formation, calcium transients,
and action potentials, although the efficiency remained low. Human iCM reprogramming was epigenetically stable. Furthermore, we
found that transforming growth factor b signalingwas important for, and improved the efficiency of, human iCM reprogramming. These
findings demonstrate that human fibroblasts can be directly reprogrammed toward the cardiac lineage, and lay the foundation for future
refinements in vitro and in vivo.INTRODUCTION
Cellular reprogramming of fibroblasts into specific cell
types without passing through a progenitor state offers
an alternative approach for generating lineages of interest
compared with directed differentiation of pluripotent
stem cells. In contrast to the ability of a single transcription
factor, MYOD, to transdifferentiate fibroblasts to skeletal
muscle cells (Davis et al., 1987), conversion of fibroblasts
to neuronal-, hepatocyte-, or cardiomyocyte (CM)-like cells
has required a combinatorial delivery of multiple trans-
cription factors or microRNAs (miRNAs) (Huang et al.,
2011; Ieda et al., 2010; Vierbuchen et al., 2010; Yoo et al.,
2011). This feature is similar to reprogramming of fibro-
blasts into induced pluripotent stem (iPS) cells, as is the
efficiency of direct reprogramming to specific cell types.
We previously reported that three developmental cardiac
transcription factors (GATA4, MEF2C, and TBX5 [GMT])
can directly reprogram cultured mouse cardiac and dermal
fibroblasts into CM-like cells (Ieda et al., 2010). These
induced CM-like cells (iCMs) had global gene-expression
profiles that were more similar to CMs than to fibroblasts,
andmany features of CMs,with a small subset ofmore fully
reprogrammed iCMs exhibiting contractile activity.Stem Cell RRecently, we (Qian et al., 2012) and others (Inagawa et al.,
2012; Song et al., 2012) showed that direct injection of
GMT-encoding retrovirus into the mouse heart reprog-
rammed endogenous nonmyocytes (largely activated
fibroblasts) into functional CMs in vivo after coronary
artery ligation. More than half of the iCMs were more fully
reprogrammed, displaying synchronous contractions with
endogenous CMs and other iCMs (Qian et al., 2012). GMT
induction in vivo resulted in decreased scar size and
improved cardiac function. Addition of HAND2 was
reported to improve GMT reprogramming of mouse
fibroblasts in vitro and in vivo (Song et al., 2012), and
Myocardin with TBX5 and MEF2C, rather than GATA4,
also reprogrammed cells in vitro (Protze et al., 2012). Simi-
larly, a cocktail of muscle-specific miRNAs generated CM-
like cells in mice (Jayawardena et al., 2012). Thus, several
strategies might reprogram cardiac fibroblasts, which
comprise 50% of cells in the adult heart (Ieda et al.,
2009), into iCMs that establish a self-reinforcingmolecular
network, and the in vivo environment may provide cues
and/or mechanical forces to promote reprogramming.
Here, we sought to identify factors that directly repro-
gram human fibroblasts toward the CM lineage in vitro,
with the notion that the in vivo environment mayeports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 The Authors 235
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Reprogramming Human Fibroblasts toward iCMsultimately permit further reprogramming. Although
we found that GMT was insufficient in human cells,
adding ESRRG and MESP1 to GMT reprogrammed human
fibroblasts derived from embryonic stem cells (ESCs),
fetal heart, or neonatal skin into cells with CM-like gene
expression and sarcomeres, albeit at low frequency.
Further addition of Myocardin and ZFPM2 (FOG2)
resulted in iCMs with more fully developed sarco-
meres, rhythmic calcium transients, and (in some)
action potentials. Finally, we found that transforming
growth factor b (TGF-b) signaling was important for,
and further improved, the efficiency of human iCM
reprogramming.RESULTS
Screening for Human Cardiac Reprogramming Factors
We investigated whether GMT could reprogram human
dermal fibroblasts (HDFs) or human cardiac fibroblasts
(HCFs), but failed to detect upregulation of the cardiac-
specific sarcomeric genes cardiac myosin heavy chain
(MHC) or cardiac troponin T (cTNT). As an assay for cardiac
markers, we used transgenic H9 human ESC (hESC)-
derived fibroblasts (H9Fs), with mCherry driven by the
mouse aMHC promoter (Kita-Matsuo et al., 2009). This
tool allowed fluorescence-activated cell sorting (FACS) to
detect cells that activated cardiac gene expression, with
a plan for validation in human primary fibroblasts
(Figure S1A available online). As described previously
(Kita-Matsuo et al., 2009), mCherry was expressed in
beating H9-derived CMs (H9-CMs), but not in other cells,
and >96% of purified mCherry+ cells expressed cTNT
(Figure S1).
To avoid contamination of CMs or cardiac progenitors in
H9Fs, embryoid bodies (EBs) differentiated over 42 days
in vitro or 3-month-old teratomas in mice were immuno-
stained with antibodies to human THY1, a surface marker
of fibroblasts (Hudon-David et al., 2007), and sorted by
FACS. This established approach yields human fibroblasts
for reprogramming studies (Hockemeyer et al., 2008;
Ramkisoensing et al., 2011). Almost all purified THY1+/
mCherry cells expressed two more fibroblast markers,
prolyl-4-hydroxylase b and vimentin, and none expressed
cTNT (Figures S1D and S1E). Although there is no
completely fibroblast-specific marker, these extra markers
suggested that the pool was mostly fibroblasts. Further-
more, the THY1+/mCherry H9Fs did not contain any
c-KIT+ stem/progenitor cells.
As in the primary fibroblasts, nomCherry+ or cTNT+ cells
were detected by FACS when GMT was overexpressed in
H9Fs, despite high levels of expression. The addition of
epigeneticmodifiers (e.g., the histone deacetylase inhibitor236 Stem Cell Reports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 TheTrichostatin A and the DNA methyltransferase inhibitor
5-aza-20-deoxycytidine), which was previously reported to
improve iPS cell reprogramming (Huangfu et al., 2008),
did not induce reprogramming.
To identify factors that along with GMT would induce
cardiac reprogramming in human cells, we selected 13
transcription factors or coactivators and three growth
factors that were enriched in H9-CMs (Figure S1I). We
used human GMT as the baseline cocktail for human
cardiac reprogramming and screened for additional human
factors that activated cardiac gene expression.
THY1+/mCherry H9Fs were transduced with a mixture
of retroviruses expressing all 19 factors, or GFP alone, as
previously described (Ieda et al., 2010). A small number
of mCherry+ cells were observed, and their proportion
increased by 10 days posttransduction (Figure 1A).
aMHC-mCherry+ cells could be quantitatively detected
by FACS after 2 weeks (Figure 1H).
To identify dispensable factors, each factor was serially
removed from the pool and the fold changes of aMHC-
mCherry+ cells were recorded to normalize day-to-day
variability. Removal of FLI1, SOX17, or WNT5A produced
more mCherry+ cells (Figure 1A), suggesting that they
inhibited cardiac reprogramming. Insulin growth factor 2
was also dispensable. Transduction with the remaining
15-factor (15F) pool resulted in a 10-fold increase in the per-
centage of mCherry+ cells to 2% (Figure 1H). Fourteen-
factor pools lacking ESRRG, MESP1, MYOCD, NKX2.5,
SRF, or ZFPM2 significantly decreased the yield ofmCherry+
cells, so these genes were retained along with GMT. For the
nine putative factors, we also examined expression of
cTNT by FACS, because the expression of both genes is a
more stringent criterion for cells that are shifting to a CM
state. SRF and NKX2.5 were omitted because their absence
increased cTNT+ cell numbers 3-fold. Removal of NKX2.5
resulted in a small but significant decrease in mCherry+
cells, but the dramatic increase in cTNT+ cells led us to
exclude this factor for more double-positive cells.
Continued refinement showed that five factors (GATA4,
MEF2C, TBX5, ESRRG, and MESP1) were sufficient to
generate aMHC-mCherry+ and cTNT+ cells, and removing
any one of these factors significantly decreased induction
efficiency. MYOCD and ZFPM2 were dispensable in the
seven-factor (7F) cocktail when removed individually, but
the five-factor (5F) reprogramming efficiency was signifi-
cantly lower than the 7F efficiency. The seven factors
induced 18.1% ± 11.2% of total fibroblasts to activate the
aMHC-mCherry reporter, and 59.0% ± 11.0% of these
also expressed cTNT, resulting in 13.0% ± 9.3% of total
fibroblasts becoming aMHC-mCherry+:cTNT+ 2 weeks
after retroviral infection (Figure 1). Similar results were
obtained with fibroblasts from 3-month-old hESC-derived
teratomas.Authors
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Figure 1. Identifying a Minimal Cocktail of Transcription Factors to Reprogram Human Fibroblasts toward CM-like Cells
(A) Screen results of aMHC-mCherry+ cell induction in H9Fs with 19 candidate reprogramming factors, and the effects of removing
individual factors from the 19-factor (19F) pool on days 4, 7, and 10 after retroviral infection (n = 3).
(B) Effects of removing individual factors from the 15F pool on aMHC-mCherry+ cell induction, as assessed by FACS (n = 3).
(C–E) Effects of removing individual factors from the nine-factor (9F) (C, n = 4), 7F (D, n = 5), or 5F (E, n = 6) pool on aMHC-mCherry+ (top)
and cTNT+ (bottom) cell induction by FACS.
(F) Removal of both MYOCD and ZFPM2, but not either one alone, from the 7F pool significantly decreased the induction of aMHC-mCherry+
cells by FACS (n = 6).
(G) Summary of results of aMHC-mCherry+ and cTNT+ induction 2 weeks after 5F (n = 11) or 7F (n = 13) retroviral infection.
(H) Representative FACS plots of aMHC-mCherry+ cells 2 weeks after infection with the indicated factors.
*p < 0.05, **p < 0.01, ***p < 0.001 compared with dashed lines.
Data represent the mean ± SD from independent experiments. See also Figures S1 and S2.
Stem Cell Reports
Reprogramming Human Fibroblasts toward iCMsAlthough no H9Fs expressed cardiac aMHC 2weeks after
GFP retroviral infection (Figure S2A), most mCherry+ cells
induced by 5F or 7F reprogramming expressed cardiac
aMHC protein by immunocytochemistry (Figure S2A).
Four weeks after infection, more than half of the mCherry+
cells also expressed cTNTand sarcomeric a-actinin, andhad
begun to assemble sarcomeric structures. Well-organized
sarcomeres were observed in 10-week reprogrammed
aMHC-mCherry+ cells, similar to H9-CMs (Figure 2A).
These reprogrammed aMHC-mCherry+ cells did not ex-
press calponin or smooth muscle actin, markers of smooth
muscle cells (Figures S2B and S2C). Importantly, primary
HDFs and HCFs that were infected with a lentivirus encod-
ing aMHC-mCherry and 7F retrovirus could also be reprog-
rammed to express a-actinin and cTNT and assemble
sarcomeres, although with lower frequency (1%–4%; Fig-Stem Cell Rures 2B, 2C, S3A, and S3B). The lower frequencymay reflect
the higher passage number of the primary fibroblasts
utilized.
By electron microscopy, enriched mitochondria and
myofibrils were observed in 5F or 7F reprogrammed cells
6weeks after retroviral infection. In 7F reprogrammed cells,
myofibrils formed sarcomeres with clear Z lines, similar to
ESC-CMs (Figures 2D, 2E, and S3C). Average sarcomere
lengths were similar in reprogrammed cells (1.08 ±
0.32 mm) and ESC-derived CMs (1.21 ± 0.38 mm; Fig-
ure S3D). The range of myofibrillar organization was
similar between human iCMs and ESC-CMs, both of which
are incomplete and less organized than adult hCMs. Thus,
cells with some CM features can be generated directly from
human fibroblasts in vitro by seven defined transcription
factors, and we will refer to these as human iCMs.eports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 The Authors 237
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Figure 2. Human Fibroblasts Reprogrammed by Seven Factors
Express Cardiac Genes and Form Sarcomere-like Structures
(A) Immunocytochemistry of aMHC-mCherry H9-CMs and H9Fs
10 weeks after retroviral infection with five or seven factors using
mCherry, cTNT, or a-actinin antibodies, revealing partial sarco-
meric organization in the cells indicated (highlighted in insets).
(B and C) Immunocytochemistry of HDFs and HCFs 6 weeks after 7F
retroviral plus aMHC-mCherry lentiviral infection reveals sarco-
meric gene expression in mCherry+ cells.
(D and E) Electron microscopic images of aMHC-mCherry+ 7F-iCMs
(D, day 45 postinduction) reveal enriched mitochondria (star) and
sarcomeres (dashed area) with Z lines (arrow) in 7F reprogrammed
cells, which were similar to H9-CMs (E, day 22 postdifferentiation).
Scale bars, 20 mm (A–C) and 1 mm (D and E). Nu, nucleus. See also
Figure S3.
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Reprogramming Human Fibroblasts toward iCMsiCM Gene Expression Resembles that of Native CMs
aMHC-mCherry+ and cTNT+ cells gradually increased
within the first 2 weeks, reaching the highest percentage
at days 14–21 before declining (Figure S4A), likely because
reprogrammed cells stopped proliferating, whereas non-
reprogrammed cells continued to proliferate (Figure S4B).
We studied the messenger RNA (mRNA) expression of
pluripotency genes in H9Fs after 7F retroviral infection
by qRT-PCR. Pluripotency genes were not significantly
activated during reprogramming (Figure S4C). We sorted
mCherry+ iCMs at 2, 3, and 4 weeks posttransduction
with five or seven factors and compared the expression of
cardiac-specific genes by quantitative PCR (qPCR).
ACTC1, ACTN2, MYH6, MYL2, MYL7, TNNT2, NPPA,
PLN, and RYR2 were significantly upregulated in 5F and
7F iCMs, but were not detected in H9Fs (Figure S5).
Although the expression levels of many iCM genes were
similar to those of H9-CMs, RYR2 and PLN levels were
lower. In contrast, expression of fibroblast-enriched genes,
including FN1,COL1A1, andCOL5A2, was lower in reprog-
rammed mCherry+ cells, similar to H9-CMs (Figure S5B).
We compared the global gene expression patterns of
5F- or 7F-induced mCherry+/THY1 iCMs (4 and 12 weeks
postinduction), H9-CMs, human fetal CMs (19 weeks old),
andH9Fs bymRNAmicroarrays in triplicate.We found that
899 cardiac and 391 fibroblast-enriched genes were differ-
entially expressed in H9Fs and human fetal CMs, with a
false-discovery rate (FDR)-controlled p value < 0.01.
When we compared these genes, we found that both 5F
and 7F aMHC-mCherry+ cells shifted considerably from
the H9F toward the H9-CM and human fetal CM pattern,
with hundreds of genes coordinately altered (Figure 3A).
We found that genes that are important for cardiac func-
tion were upregulated more highly in 7F than in 5F iCMs
(Figure 3B), including CKM, MYH6, MYH7, TNNC1, and
SLC8A1. A microarray assay also revealed the progressive
repression of fibroblast genes between 4 and 12 weeks after
induction of reprogramming factors (Figure 3A), which is
consistent with the higher percentage of reprogrammed
iCMs with well-organized sarcomeres 12 weeks after induc-
tion (Figures S5C and S5D).
Primary fibroblasts (HDFs) were transduced with a
lentivirus encoding aMHC-mCherry and the 7F retrovirus
cocktail, so that the reprogrammed aMHC-mCherry+/
THY1 HDF-iCMs could be purified for global gene expres-
sion assay at 4 and 12 weeks postinduction. Like the H9F-
iCMs, the global gene-expression pattern in HDF-iCMs
shifted toward the cardiac lineage; however, downregula-
tion of fibroblast genes occurred even more rapidly than
in H9F-iCMs (Figure 3A).
Wenext compared the degree of gene expression changes
in human iCMs with published values for in vitro mouse
iCM gene expression induced by GMT (Ieda et al., 2010).Authors
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Reprogramming Human Fibroblasts toward iCMsAnalysis of orthologous gene expression indicated that, at
the global gene-expression level, humanfibroblastswere re-
programmed into CM-like cells by seven factors to a degree
comparable to that observed for mouse iCMs reprog-
rammed by GMT in vitro (Figure 3C). Although we (Qian
et al., 2012) and others (Song et al., 2012) reported that
GMT can induce more complete reprogramming in vivo
with resulting cardiac repair after injury, the global tran-
scriptome of in vivo mouse iCMs has not been described.
We therefore performed mRNA microarrays of isolated
in vivo mouse iCMs and computationally analyzed the
transcriptome changes aswe didwhenwe comparedmouse
and human in vitro iCMs. The isolated in vivo reprog-
rammed mouse iCMs and mouse adult CMs showed very
similar global gene-expression patterns and thus were clus-
tered into one group of cells (Figure 3C). This observation
raises the possibility that the degree of reprogramming of
human iCMs in vitro may result in more complete reprog-
ramming in the in vivo environment.
Given the heterogeneity of pooled iCMs, we sought to
examine individual cells to correlate the expression of
reprogramming factors with the degree of reprogramming.
Using microfluidic technology, we isolated individual
aMHC-mCherry+ iCMs at 4 or 12 weeks and assayed each
reprogramming factor and a panel of cardiac- or fibro-
blast-enriched genes at the single-cell level. Although the
degree to which gene expression shifted toward the CM
lineage varied, most cells were more similar to H9-CMs
(Figure 3D). Cardiac gene expression was higher after
12 weeks, and fibroblast genes were strikingly downregu-
lated between 4 and 12 weeks. Importantly, virtually all
of the aMHC-mCherry+ iCMs had high levels of GATA4,
MEF2C, TBX5, andMYOCD, butmany reprogrammed cells
expressed no ESRRG or ZFPM2. MESP1 was expressed in
most cells, but at lower levels. Thus, single-cell studies
may reveal the essential factors for an individual cell to
shift toward a CM state.
Human iCMs Are Epigenetically Reprogrammed to a
CM-like State
To identify epigenetic modification patterns, we analyzed
the DNA and histone methylation status of loci that reflect
reprogramming from cardiac fibroblasts to iCMs. Bisulfite
genomic sequencing in the promoter regions of MYH6,
MYH7, and MYL7 in H9Fs, 2-week reprogrammed aMHC-
mCherry+ iCMs, and aMHC-mCherry+ H9-CMs revealed
that the three promoters were hypermethylated in H9Fs,
as expected, but relatively demethylated in iCMs, similar
to H9-CMs (Figure 4A). The 7F iCMs had slightly less
methylation at the MYH7 and MYL7 promoters than the
5F iCMs.
Enrichment of trimethylated histone H3 of lysine
27 (H3K27me3) and lysine 4 (H3K4me3), which markStem Cell Rtranscriptionally inactive or active chromatin, respectively,
was analyzed in H9Fs, 2-week 7F aMHC-mCherry+ iCMs,
and aMHC-mCherry+ H9-CMs. In aMHC-mCherry+
iCMs, H3K4me3 was significantly enriched at the pro-
moters of all cardiac-specific genes tested, and depleted at
the COL1A1 promoter, at which H3K27me3 increased to
levels comparable to those observed in aMHC-mCherry+
H9-CMs (Figure 4B).
Using a doxycycline (Dox)-inducible retroviral system,
aMHC-mCherry was induced in H9Fs as early as 3 days
after infection with seven factors and Dox administration,
whereas no mCherry+ cells were seen without Dox (Figures
4C, 4D, and S6). After 2 weeks, Dox was withdrawn. One
week later, reprogrammed iCMs maintained aMHC-
mCherry expression with an efficiency comparable to
that observed for the noninducible system at 3 weeks
(10%; Figure 4D), and they also continued to develop
early sarcomeric structures (Figure S6C). The percentage
of iCMs in culture decreased over the first several weeks
as nonreprogrammed fibroblasts continued to divide,
resulting in dilution of iCMs that exited the cell cycle.
However, as fibroblasts started to senesce, the percentage
of iCMs remained stable between 3 and 5 weeks after Dox
withdrawal (Figure 4D). Expression of aMHC-mCherry
and sarcomeric a-actinin were maintained in reprog-
rammed cells even 3 weeks after Dox withdrawal
(Figure S6D), suggesting that these iCMs were stably
reprogrammed, although this time point is too early for
more mature sarcomeric structure.
Human iCMs Exhibit Some Cardiac Physiological
Features
Electrical field stimulation triggered 20% of 4-week-
inducedmCherry+ iCMs to generate regular Ca2+ transients
similar to those observed in H9-CMs (Figures 5A; Movie
S1). Reprogrammed 7F-iCMs responded to caffeine with
large Ca2+ transients similar to those observed in H9-CMs
(Figure 5B). HDF-derived iCMs also exhibited calcium tran-
sients (Figure 5C; Movie S2). Ten weeks after induction, a
resting membrane potential of 73.4 ± 8.4mV (n = 6)
was detectable in aMHC-mCherry+ iCMs, similar to the
hyperpolarized level of adult quiescent CMs (Wang et al.,
1993). Action potentials were elicited in some iCMs (n =
3 out of >200 recorded cells), suggesting that this com-
bination of factors can induce some cells to be more fully
reprogrammed even in vitro, but most are partially
reprogrammed (Figure 5D).
TGF-b Signaling Promotes Human Cardiac
Reprogramming
To probe additional biological pathways that may regulate
human cardiac reprogramming, we tested eight com-
pounds that affect iPS cell reprogramming (Huangfueports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 The Authors 239
CA B
D
Figure 3. Human iCMs Are Transcriptionally Reprogrammed toward the CM State
(A) Heatmap image of microarray data illustrating gene expression profiles for the panel of genes that were differentially
expressed between H9Fs and human fetal CMs evaluated in H9Fs, HDFs, human fetal CMs, H9-CMs, 5F- and 7F-iCMs, and HDF-
derived iCMs (4 and 12 weeks postinduction); range of ±256-fold (log28) changes. The average level in three H9F samples was used
as a baseline for comparison. Groups 1 and 2 include the genes that were upregulated or downregulated in CMs and iCMs compared
with H9Fs.
(B) Heatmap of gene expression profiles for a panel of cardiac genes in group 1 of (A) that were more highly upregulated in 7F-iCMs
compared with 5F-iCMs at 4 and 12 weeks after reprogramming.
(C) Correlation heatmap of orthologous gene expression for the panel of genes that were differentially expressed between
fibroblasts and CMs evaluated in human iCMs reprogrammed by 5F or 7F and GMT-reprogrammed mouse (m) in vitro and in vivo iCMs. The
correlation is indicated by color range; the scale along the values1, 0, and 1 indicates perfect anticorrelation, no correlation, or perfect
correlation, respectively.
(legend continued on next page)
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Figure 4. Human Fibroblasts Are Stably Reprogrammed into iCMs
(A) Bisulfite genomic sequencing forMYH6,MYH7, andMYL7 promoter methylation status in H9Fs, 5F- and 7F-iCMs (2 weeks postinfection),
and H9-CMs. Open circles indicate unmethylated CpG dinucleotides; closed circles indicate methylated CpGs.
(B) The promoters of ACTC1, ACTN2, RYR2, TNNT2, PLN, and COL1A1 were analyzed by ChIP for trimethylation status of histone H3 of lysine
27 or 4 (H3K27me3 or H3K4me3) in H9Fs, 7F-iCMs, and H9-CMs. n = 3, *p < 0.05, **p < 0.01 versus H9Fs. Data represent the mean ± SD
from independent experiments.
(C) Strategy to determine the temporal requirement of reprogramming factors for human cardiac reprogramming.
(D) FACS plots of aMHC-mCherry+ cells after retroviral infection without Dox (no Dox) or with 2-week Dox induction (+Dox 2W) followed by
Dox withdrawal (Dox) for 1, 3, and 5 weeks.
See also Figure S6.
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Reprogramming Human Fibroblasts toward iCMset al., 2008; Lin et al., 2009) for their capacity to influence
7F-mediated cardiac reprogramming. Although none
increased the yield of aMHC-mCherry+ cells, SIS3 inhibited
induction of aMHC-mCherry+ cells (Figure 6A). SIS3
specifically inhibits SMAD3 (Jinnin et al., 2006), a tran-
scription factor that is activated downstream of TGF-b
signaling, suggesting that activation of the TGF-b
signaling pathway is important for 7F human cardiac
reprogramming. Adding activin A or TGF-b1 did not(D) Heatmap of single-cell gene expression by qPCR using microflu
represents an individual cell, and each vertical column represents th
color range.
See also Figures S4 and S5.
Stem Cell Renhance 7F reprogramming, but TGF-b1 more than
doubled the number of aMHC-mCherry+ cells generated
by 5F reprogramming, similar to the levels observed with
7F reprogramming (Figure 6B). SIS3 (10 mM) reversed the
effect. We did not find any evidence that the increase in
iCM numbers was the result of increased proliferation of
iCMs in a dye-dilution assay (Figure 6C), indicating that
TGF-b1 likely plays an early inductive role in the reprog-
ramming process.idics (Fluidigm) in the cell types indicated. Each horizontal row
e levels of a single gene. Gene-expression level is indicated by the
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Figure 5. Human iCMs Exhibit Ca2+ Flux and Action Potentials
(A) Top: Electrical field stimulation induces Ca2+ transients, as
shown by Ca2+ imaging (minimal (Min) and maximal (Max) levels),
in aMHC-mCherry+ 7F-iCMs 4 weeks after retroviral infection.
Bottom: A representative trace of Ca2+ transients recorded from
reprogrammed aMHC-mCherry+ 7F-iCMs (left, n = 9) is similar to the
trace recorded from 3-week-old H9-CMs (right).
(B) A representative trace of caffeine (20 mM)-induced Ca2+
transients recorded from reprogrammed 8-week aMHC-mCherry+
7F-iCMs (top, n = 15) is similar to the trace recorded from 4-week-
old H9-CMs (below).
(C) Electrical field stimulation induces Ca2+ transients, as shown by
Ca2+ imaging (Min and Max level, top) and a representative trace
(bottom), in HDF-derived iCMs 6 weeks after 7F retroviral infection.
(D) Typical action potential measured in 7F-iCMs (n = 3) 10 weeks
after induction in comparison with H9-CMs (right).
Scale bars, 20 mm (A and C). See also Movies S1 and S2.
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Here, we have shown that GATA4, MEF2C, TBX5, ESRRG,
MESP1, MYOCD, and ZFPM2 together reprogram human
fibroblasts toward a CM-like state. Human iCMs upregu-242 Stem Cell Reports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 Thelated hundreds of CM-enriched genes, downregulated
hundreds of fibroblast-enriched transcripts, and assembled
sarcomeres. Reprogrammed cells were epigenetically
similar to CMs at the loci tested. Although most cells were
partially reprogrammed, 20% generated functional Ca2+
transients, and some fired action potentials similar to those
of human CMs. TGF-b signaling was important for, and
improved the efficiency of, human iCM reprogramming.
In addition to GMT, which coactivates the expression of
many cardiac genes (Garg et al., 2003; Ghosh et al., 2009;
He et al., 2011), ESRRG and MESP1 also promoted human
cardiac reprogramming. ESRRG (also known as nuclear
receptor NR3B3) is a key regulator of mitochondrial
biogenesis. Overexpressing ESRRG in rat neonatal cardiac
myocytes activates transcripts encoding sarcoplasmic
reticulum Ca2+-handling proteins and contractile protein
isoforms that are specifically expressed in adult ventricles
(Dufour et al., 2007). MESP1 acts as a key transcriptional
regulator of cardiovascular specification during develop-
ment and resides at the top of a gene network that
determines cardiovascular cell fate (Bondue et al., 2008).
Interestingly, MESP1 and ETS2 together reprogram HDFs
into cardiac progenitor-like cells (Islas et al., 2012), high-
lighting the central role of MESP1 in cardiac cell fate.
Adding MYOCD and ZFPM2 to the 5F mix quantita-
tively and qualitatively improved human cardiac repro-
gramming. Myocardin, encoded by MYOCD, is a smooth-
and cardiac-muscle-enriched transcriptional coactivator of
serum response factor (Wang et al., 2001). It maintains
CM structure and sarcomeric organization, and its cell-
autonomous loss in CMs triggers programmed cell death
(Huang et al., 2009). Although Myocardin promotes the
smooth muscle fate in mouse fibroblasts (Chen et al.,
2002), in the context of other cardiac transcription factors
shown here, it appears to activate cardiac rather than
smooth muscle genes. The zinc-finger protein ZFPM2
(also known as friend of Gata-2 [FOG2]) is a cofactor of
GATAtranscription factors and is essential inheartmorpho-
genesis (Tevosian et al., 2000; Svensson et al., 2000). ZFPM2
activates and represses the expression of GATA target genes
(Lu et al., 1999). Single-cell analyses suggest that MYOCD
and MESP1, with GMT, were most consistently activated
in reprogrammed cells, and highlight the value of inter-
rogating individual cells among heterogeneous reprog-
rammed cells. These transcription factors likely function
in interrelated reinforcingnetworks to regulate gene expres-
sion. Addition of TGF-b1 may substitute for MYOCD and
ZFPM2, and future studies will explore this key signaling
cascade in cardiac reprogramming.
Although the conversion of human fibroblasts to cells
with broad gene expression shifts and development of
sarcomeres is encouraging, it takes longer to reprogram
human cells than mouse cells, and the process remainsAuthors
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Figure 6. Human iCM Reprogramming Involves TGF-b1
Signaling
(A) Results from exposure to eight small molecules show the
relative degree of aMHC-mCherry+ cell induction 2 weeks after 7F
retroviral infection (n = 3). Cells were exposed to individual com-
pounds from days 1–14 after 7F infection at the following doses:
A-83-01 (0.5 mM), Chir99201 (3 mM), forskolin (5 mM), LY-2157299
(300 nM), PMA (100 nM), SIS3 (10 mM), SB415286 (10 mM), and
SB431542 (10 mM). Data represent the mean ± SD from indepen-
dent experiments.
(B) Effects of activin A (20 ng/ml) and TGF-b1 (20 ng/ml) on aMHC-
mCherry+ cell induction 2weeks after retroviral infectionwith five or
seven factors (n = 3). The inset panel represents the effects of
TGF-b1 at different doses. *p < 0.001. The SIS3 dosewas 10mM. Data
represent the mean ± SD from independent experiments.
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Reprogramming Human Fibroblasts toward iCMsinefficient. Very recently, it was reported that human fibro-
blasts could be reprogrammed toward a cardiac cell fate by
four cardiac transcription factors and two miRNAs, but
only rare beating cells were observed after a long period
in culture (Nam et al., 2013). Consistent with this, most
cells in our study were also only partially reprogrammed,
with no visible contractile activity after a long time in
culture. We found that the resting membrane potential in
human iCMs was stably hyperpolarized, similar to adult
quiescent CMs but in contrast to the less mature ESC-
derived fetal CMs (Fu et al., 2011). Since some cells could
elicit good cardiac action potentials following electrical
stimulation, it will be important to identify the epigenetic
barriers that prevent more complete reprogramming.
Efforts to develop functional screens with small molecules
and secreted proteins that may improve reprogramming
in vitro are under way. Nevertheless, our identification of
a cocktail of factors that globally shift fibroblasts toward a
CM-like state is an important step. Based on the com-
parable degree of reprogramming we observed between
human and mouse in vitro iCMs, we speculate that the
human factors reported here may function better in vivo,
as is the case for GMT-induced reprogramming in mice
(Qian et al., 2012; Song et al., 2012). It will be important
to determine whether the five or seven factors described
here more fully reprogram iCMs in vivo, perhaps in a
nonhuman primate model.EXPERIMENTAL PROCEDURES
hESC Culture and Differentiation
hESCs and discarded and deidentified human tissues were used in
accordance with the policies of the University of California, San
Francisco, Institutional Review Board. Stable aMHC-mCherry-
expressing H9 hESCs (Kita-Matsuo et al., 2009) were grown on
Matrigel (BD) in mTeSR1 media (StemCell Technologies). CMs
were differentiated using the matrix sandwich method (Zhang
et al., 2012) and harvested at 3 weeks postdifferentiation by
FACS Aria II (BD Biosciences).
For fibroblast differentiation from aMHC-mCherry H9 hESCs,
EBs were formed from enzymatically dispersed hESCs suspended
in low-attachment plates for 7 days, and then plated on gelatin-
coated dishes and cultured in medium (Dulbecco’s modified
Eagle’s medium [DMEM]/20% fetal bovine serum [FBS]) for(C) A cell proliferation assay using CFSE revealed that activin A and
TGF-b1 did not increase the proliferation of iCMs. Noninfected H9Fs
(black line) were used as a positive control of cell division, as
indicated by decreased fluorescence intensity. Mitomycin C (MC)-
treated H9Fs (gray line) were used as negative controls for pro-
liferation and demonstrated high fluorescence intensity. H9Fs
were treated with activin A or TGF-b1 from days 1–14 after 5F or
7F infection. Images are representative of three independent
experiments.
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Reprogramming Human Fibroblasts toward iCMsanother 14 days. Alternatively, aMHC-mCherry H9 cells were sub-
cutaneously transplanted into NOD-SCID mice to form teratomas
as previously described (Thomson et al., 1998). Teratomas were
removed 3 months after cell injection, minced, and cultured in
medium (DMEM/20% FBS). The migrated cells were harvested
and filtered with 40 mm cell strainers (BD). The screening experi-
ments to identify the minimal combination of reprogramming
factors for human cardiac reprogramming were done only in
EB-differentiated fibroblasts, and other results of characterization
were collected from both types of H9Fs, which showed no signifi-
cant difference.
For aMHC-mCherry/THY1+ human-cell sorting, cells were
incubated with allophycocyanin (APC)-conjugated anti-human
THY1 antibody (eBioscience) and sorted by FACSAria II (BD Biosci-
ences). The purified fibroblasts were cultured and expanded in
M106 with a 1:3 split ratio, and then frozen for reprogramming
experiments. A total of 33 batches of fibroblasts were differentiated
from EBs or teratomas. Eight of these batches did not proliferate
well after purification by FACS with THY1 staining and were not
used in our studies.
There was some variance of reprogramming efficiency among
different batches of fibroblasts; therefore, the data for each exper-
iment were collected from more than three different batches of
fibroblasts. We observed that the reprogramming efficiency was
dramatically decreased in fibroblasts with a high passage number
(n > 13); therefore, fibroblasts with a low passage number (n =
6–12) were used in the current study. Fibroblasts were reseeded
on gelatin-coated plates at a density of 104 cells/cm2 1 day before
retroviral infection.
HDFs were purchased from PromoCell. HCFs were isolated from
discarded and deidentified human heart tissue, and THY1+ HCFs
were purified by FACS and expanded as described above.Molecular Cloning and Retroviral Infection
To construct pMXs retroviral vectors, we amplified the coding
regions of candidate genes by PCR and subcloned them into
pMXs vector. The pMXs retroviral vectors and retroviral packaging
vectors (Alstem) were transfected into HEK293 FT cells using
FuGENE 6 (Promega) to generate viruses with 3 3 106 IFU/ml
titer. The viruses yielded a transduction efficiency of 80%–90%
in human fibroblasts, as indicated by GFP retroviral infection.
Virus-containing supernatants were pooled and used for transduc-
tion of human fibroblasts. The virus-containing medium was
replaced with 10% FBS of DMEM/M199 (4:1) medium 24 hr after
retroviral infection and changed every 3 days. RPMI1640 with
B27 was used 2 weeks after retroviral infection to curb proliferative
cell overgrowth in some long-time-cultured iCMs.
For the Dox-inducible system, we used the Retro-X-Tet-ON
Advanced Systems (Clontech) according to the manufacturer’s
recommendations. To construct pRetro-X-Tight-cDNA vectors,
we amplified the coding regions of EGFP, ESRRG, GATA4,
MEF2C, MESP1, TBX5, MYOCD, and ZFPM2 by PCR and subcl-
oned them into pRetro-X-Tight-Puro vector. The pRetro-X-Tet-
On Advanced-Neo or pRetro-X-tight-cDNA retroviral vectors and
packaging constructs (Alstem) were transfected into HEK293 FT
cells with FuGene 6 (Promega) to generate viruses, and virus-
containing supernatants were collected after 48 hr. Cells were244 Stem Cell Reports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 Thetransduced with Retro-X-Tet ON and Retro-X-Tight-cDNA over-
night supplemented with 5 mg/ml polybrene, and purified
by positive selection with puromycin and neomycin. Dox
(100 ng/ml) was used for gene induction.FACS Analyses and Sorting
For mCherry expression analyses, cultured cells were dissociated
and analyzed on the LSR-II (BD) with FlowJo software. aMHC-
mCherry/THY1+ H9Fs were purified with APC-conjugated anti-
human THY1 antibody (eBioscience) (Ieda et al., 2009). For
aMHC-mCherry+/cTNT+ assay, cells were fixed with 4% parafor-
maldehyde (PFA), permeabilized with 0.5% w/v saponin, and
stained with anti-dsRed (AbCam) and anti-cTNT (Thermo Sci-
entific) antibodies, followed by secondary antibodies conjugated
to Alexa-594 and Alexa-647 (Invitrogen). For c-KIT analysis, cells
were incubated with PECy5.5-conjugated anti-c-KIT antibody.
We used undifferentiated H9 ESCs as a positive control for c-KIT
staining.Immunocytochemistry and Histology
Cells were fixed in 4% PFA for 15 min at room temperature,
permeabilized with 0.5% w/v saponin, blocked in 5% normal
goat serum, and incubated with primary antibodies against red
fluorescent protein (AbCam), cardiac aMHC (AbCam), cTNT
(Thermo Scientific), sarcomeric a-actinin (Sigma Aldrich), calpo-
nin (Sigma Aldrich), smooth muscle actin (Sigma Aldrich), and
vimentin (Progen). We used secondary antibodies conjugated to
Alexa-488 or -594 (Molecular Probes) and costained cells with
DAPI (Invitrogen) during the secondary incubation step.Transmission Electron Microscopy
For transmission electron microscopy, reprogrammed aMHC-
mCherry+ H9Fs (D45 after 7F induction) and H9-CMs (D22
postdifferentiation) were fixed in 1% formaldehyde and 2% glutar-
aldehyde in 0.1 M sodium cacodylate buffer pH 7.4, postfixed in
2% osmium tetroxide in the same buffer, block stained with 2%
aqueous uranyl acetate, dehydrated in acetone, infiltrated, and
embedded in LX-112 resin (Ladd Research Industries). Samples
were ultrathin sectioned on a Reichert Ultracut S ultramicrotome
and counterstained with 0.8% lead citrate. Grids were examined
on a JEOL JEM-1230 transmission electron microscope (JEOL
USA) and photographed with a Gatan Ultrascan 1000 digital
camera (Gatan). The sarcomere structure was identified between
two Z bands with continued myofibril connection, and the
sarcomere length was quantified by Axiovision (Zeiss).qRT-PCR
Total RNA was isolated from cells and qRT-PCR was performed on
an ABI 7900HT (Applied Biosystems) with the TaqMan probes
(Applied Biosystems) listed below. The mRNA levels were normal-
ized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA.
The following TaqMan probes (Applied Biosystems) were
used: ACTC1 (Hs01109515_m1), ACTN2 (Hs00153809_m1),
NPPA (Hs00383230_g1), MYH6 (Hs00411908_m1), MYL2 (Hs001
66405_m1), MYL7 (Hs00221909_m1), TNNT2 (Hs00165960_m1),Authors
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Reprogramming Human Fibroblasts toward iCMsATP2A2 (Hs01566028_g1), PLN (Hs00160179_m1), RYR2
(Hs00892842_m1), COL1A1 (Hs00164004_m1), COL5A2 (Hs00
893878_m1), FN1 (Hs00365052_m1), and GAPDH (Hs0
2758991_g1), CNN1 (Hs00154543_m1), ACTA2 (Hs00426835_g1),
OCT4 (Hs00742896_s1), NANOG (Hs02387400_g1), SOX2
(Hs01053049_s1), and TDGF1 (Hs02339496_g1).
For single-cell qPCR assay, purified H9Fs, H9-CMs, and reprog-
rammed aMHC-mCherry iCMs were harvested by the C1 Single-
Cell Auto Prep System (Fluidigm) followed by reverse transcription
and preamplification. qPCR was performed with the use of the
BioMark HD System (Fluidigm) to profile gene expression in single
cells, and analyzed with the SINGuLAR Analysis Toolset
(Fluidigm).Whole-Transcriptome Assay
After 4 or 12 weeks in culture, uninfected H9Fs and 5F and 7F
aMHC-mCherry+:THY1 iCMs were collected by FACS. RNA was
extracted using the PicoPure RNA Isolation Kit (Arcturus). RNA
was hybridized to the Affymetrix HumanGene 1.0 STArray.Micro-
arrays were performed in triplicate from independent biological
samples according to the standard Affymetrix GeneChip protocol.
Data were analyzed using the Affymetrix Power Tool (APT, version
1.8.5). For data analysis, linear models were fitted for each gene on
the sample group to derive estimated group effects and their
associated significance with the limma package (Smyth, 2004) in
R/Bioconductor. Moderated t statistics and the associated p values
were calculated. We adjusted the p values for multiple testing by
controlling for FDR by the Benjamini-Hochberg method. Gene
annotations were retrieved from Affymetrix (version Nov. 12,
2007). Differential gene expression was defined using the statis-
tics/threshold combination. Genes that were differentially
expressed in at least one comparison (FDR-adjusted p < 0.01) are
shown in Figure 4A.
For an orthologous comparison with gene expression from
mouse in vivo iCMs, mouse adult CMs were isolated from three
reprogrammed (GMT-injected) and three control (dsRed-injected)
Periostin-Cre:Rosa-Tomato mice 4 weeks after coronary ligation
and intramyocardial viral delivery, as previously described (Qian
et al., 2012). Fifty reprogrammed iCMs (based on the presence of
red fluorescence) or endogenous CMs from each GMT-injected or
dsRed-injected heart were collected using a micropipette. The cells
were processed with RNA isolation and purification using the
PicoPure RNA Isolation Kit (Arcturus). The microarray assay was
performed and data were analyzed as described above. For compar-
ison of orthologous gene expression, genes with 1:1 orthologs
between human and mouse that were differentially expressed in
human fibroblasts and CMs were identified at an FDR of 0.05.
The Pearson rho correlation was then calculated for expression of
these genes across all data sets.Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assays were performed
on H9Fs, 7F-iCMs, and H9-CMs with the use of the Imprint
Chromatin Immunoprecipitation Kit (Sigma). Antibodies against
H3K27me3 and H3K4me3 were obtained from Active Motif, and
normal rabbit immunoglobulin G was obtained from Cell
Signaling Technology. Primers for qPCR custom TaqMan gene-Stem Cell Rexpression assays (Applied Biosystems) were designed online to
target the core promoters of cardiac genes. The primers for qPCR
custom TaqMan gene-expression assays (Applied Biosystems)
included ACTC1_CP (AIT95RY), ACTN2_CP (AIS07LQ), RYR2_CP
(AIRR9FI), PLN_CP (AJ6RM9Q), TNNT2_CP (AIQJA9A), and
COL1A1_CP (AJAAYRZ).
Bisulfite Genomic Sequencing
Bisulfite treatment was performed using the Epitect Bisulfite Kit
(QIAGEN). Amplified products were cloned into pCR2.1-TOPO
(Invitrogen). Nine to ten randomly selected clones were sequenced
with the M13 forward and M13 reverse primers for each gene.
The following PCR primer sequences were used for bisulfite
sequencing: MYH6-Sense: GGGAGGAATGTGTTTAAGGATTAA
AAA; MYH6-Antisense: TACAAAACATCCCACCCCAAACCTC;
MYH7-Sense: ATTGGTTGTTTGTGGTTTTGGTGGT; MYH7-Anti-
sense: TAAAAACATTTCCCCCAAACTCCCCC; MYL7-Sense: TTG
TTAGGATGGATAGATAGTAGGATGTTATA; and MYL7-Antisense:
CCCAAAAACCAACACCTAAAAAACC.
Ca2+ Imaging and Electrophysiology
Cells were labeled with Fluo-4-AM (Invitrogen) for 30min at 37C,
washed, and incubated for an additional 30 min at room
temperature to allow de-esterification of the dye. Fluo-4-labeled
cells were analyzed by Axio Observer (Zeiss) with MiCAM02
(SciMedia) at 37C. Ca2+ transients were elicited in reprogrammed
aMHC-mCherry+ cells by electrical field stimulation (20 V, 5 ms at
1 Hz or 0.5 Hz).
Electrophysiological analyses were performed on iCMs 4 or
10 weeks after 7F transduction, by whole-cell recording with an
Axopatch 200B amplifier and pClamp10 software (Axon Instru-
ments). Glass patch pipettes, with typical resistances of 2–4 MU,
were directly attached onto single iCMs (identified by mCherry
expression) for whole-cell recording in Tyrode’s bath solution.
Using the current-clamp model, action potentials were elicited in
single mCherry+ cells with stimulations of 2 nA for 2 ms.
Cell Proliferation Assay
Cell proliferation was investigated with the use of carboxyfluores-
cein diacetate succinimidyl ester (CFSE; Invitrogen). The day after
retroviral infection, H9Fs were incubated with 5 mM CFSE, which
passively diffuses into cells and yields highly fluorescent CFSE
when the acetate groups are removed by cytoplasmic esterases.
The CFSE is divided equally among daughter cells following
division (Lyons et al., 2001). Cumulative cell proliferation from
day 1 to day 14 can be evaluated by analyzing the fluorescence
intensity 2 weeks after retroviral induction. H9Fs treated with
mitomycin C (10 mg/ml) just before CFSE treatment were used as
a negative control (higher fluorescence) and H9Fs were used as a
positive control (lower fluorescence) for cell division.
Small-Molecule Compound Testing
H9Fs were treated with individual small-molecule compounds,
activin A, or TGF-b1 the day after 5F or 7F retroviral infection,
and media with fresh compounds were changed every 3 days for
2 weeks, at which time the reprogramming efficiency was
evaluated by FACS. The following doses were used in the currenteports j Vol. 1 j 235–247 j September 10, 2013 j ª2013 The Authors 245
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Reprogramming Human Fibroblasts toward iCMsstudy: A-83-01 (0.5 mM), Chir99201 (3 mM), forskolin (5 mM),
LY-2157299 (300 nM), phorbol-12-myristate-13-acetate (PMA,
100 nM), SIS3 (10 mM), SB415286 (10 mM) SB431542 (10 mM),
activin A (20 ng/ml), and TGF-b1 (20 ng/ml).
Statistical Analyses
Data were collected from independent biological replicates with
the indicated n values and are expressed as mean ± SD. Differences
between groups were examined for statistical significance using
Student’s t test, ANOVA, or Kruskal-Wallis followed by Tukey’s
test for multiple comparisons; p values < 0.05 were regarded as
significant.
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